Danny Altmann heads a lab at the Hammersmith Hospital Campus of Imperial, with expertise in the HLA system, antigen discovery, T cell subsets and NK cells. Key research interests are the immunology of infectious disease including severe bacterial infections, Zika virus and Chikungunya virus. Other projects focus on autoimmune disease including the role of the microbiota in rheumatoid arthritis and autoimmune immunotoxicity in cancer immunotherapy. He serves as editor for a number of journals and has roles with a number of funding organisations.
et al., 2019, Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C, Proceedings of the National Academy of Sciences of the United States of America, ISSN:0027-8424
et al., Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised crossover trial, Gut, ISSN:0017-5749
Altmann DM, 2019, "Just 17 if you know what I mean' ... but what do we really mean to say about Th17 immunity?, Immunology, Vol:156, ISSN:0019-2805, Pages:297-298
et al., 2018, Immune control of Burkholderia pseudomallei––common, high-frequency T-cell responses to a broad repertoire of immunoprevalent epitopes, Frontiers in Immunology, Vol:9, ISSN:1664-3224
Altmann D, 2018, Don't let peer review panels for grant awards turn into a wolf pack., Nature, Vol:555, Pages:311-311
et al., 2018, T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses, Scientific Reports, Vol:8, ISSN:2045-2322
et al., 2017, Guillain-Barre syndrome and arboviral infection in Brazil, Lancet Infectious Diseases, Vol:17, ISSN:1473-3099, Pages:693-694